Remapping Procedure for Atrial Fibrillation

(PRECLUDE Trial)

This trial examines the effectiveness of pulsed field ablation (PFA) for individuals with atrial fibrillation who also require a device to block a part of the heart. The researchers aim to determine if the initial treatment remains effective or if additional treatment is necessary. This trial suits individuals with atrial fibrillation symptoms seeking a non-drug option for clot prevention. Participants should not have undergone previous treatments like ablation or certain heart procedures. As an unphased trial, it offers participants the chance to contribute to groundbreaking research in non-drug treatment options for atrial fibrillation.

The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that the remapping procedure, which includes pulsed field ablation (PFA), is generally safe for treating atrial fibrillation. One study found no major harmful effects directly linked to the device or procedure. Another study reported that only 3.0% of participants experienced significant side effects, indicating that very few people had problems. A different report showed a very low major complication rate of just 1.25%. These findings suggest that most patients handle the treatment well.¹²³⁴⁵

Unlike the standard treatments for atrial fibrillation, which often involve medication or catheter ablation alone, the remapping procedure combines a novel approach with a Left Atrial Appendage Occlusion (LAAO) implant and potentially additional ablation. Researchers are excited about this method because it offers a more comprehensive approach to managing atrial fibrillation by not only targeting the irregular heart rhythms but also addressing the risk of stroke with the LAAO implant. This dual-action approach could lead to better long-term outcomes for patients by reducing both symptoms and complications associated with atrial fibrillation.

Research has shown that the technique used in pulsed field ablation (PFA) for treating atrial fibrillation yields promising results. One study found that 93.5% of the treated areas in the heart remained isolated, a key indicator of success. Other studies have reported success rates of 50-70% for similar procedures. These findings suggest that PFA effectively helps many patients maintain a regular heart rhythm. This procedure is considered a safe and effective method for managing atrial fibrillation.⁶⁷⁸⁹¹⁰